AQEMIA’s Post

AQEMIA reposted this

View profile for Maximilien Levesque

CEO & co-founder @ AQEMIA | AI, Quantum & Statistical Mechanics

🎉 Proud to share that AQEMIA has renewed its place in the #FrenchTech120 Class of 2025. The #FT120 program, led by the French government, supports the 120 most successful and mature French startups — selected through rigorous criteria including fundraising and growth. This recognition reflects the commitment of our teams in Paris and London to pushing the boundaries of what’s possible in #pharma and #biotech — by powering generative AI with atomic-scale physics to invent treatments for diseases with no cure yet. It’s the right moment to say thank you: 🧖  To our team in London and Paris, 🕵  To our investors — Cathay Innovation, Wendel, Eurazeo, Bpifrance Large Venture, Elaia — who have entrusted €100 millions in total to do exactly what's written above: Finding drugs, 🤝  To our trusted partners, 🇫🇷  And to the French startup ecosystem, pushed forward by Clara Chappaz, Julie Huguet and ultimately Emmanuel Macron. - I want to finish with a personal note: What a journey with Emmanuelle Martiano Rolland since 2019 … ;). Thank you Emmanuelle.

  • No alternative text description for this image
Maximilien Levesque

CEO & co-founder @ AQEMIA | AI, Quantum & Statistical Mechanics

1mo

Congrats AQEMIA on joining the FT120! Great to see you among France’s top tech players. At French Tech Amsterdam, we’d be happy to support your growth in Europe and to involve you in the upcoming Bio/MedTech opportunities here.

👏 Bien mérité, Maximilien

Like
Reply
Cheshta Gaur

CEO and Founder @ForteFocus | Biotech Signal Systems + Narrative AI | We Turn Invisible Innovations Into Industry Gravity | Selective: Only the ones NecroNex detects | Visibility = Valuation

1mo

Maximilien Levesque This is the kind of recognition that isn’t just a badge — it’s a statement. AQEMIA isn’t building hype-fueled AI, it’s distilling signal from first principles. Physics-native drug design will define the next decade of biotech IP. Honored to witness this unfold in real time.

Like
Reply
Anil Nair

In Silico Discovery, Designing drugs by leveraging SBDD, MD simulations and machine learning

1w

Congratulations, Maximilien

Like
Reply
David Darmon

Membre du Directoire, Directeur Général chez Wendel

1mo

Félicitations Maximilien !

Like
Reply
Déborah Loye

Leading the value creation team at Eurazeo Tech (Venture & Growth)

1mo

❤️❤️❤️

Like
Reply
Sofia DAHOUNE

Investor & Advisor | Specialist in science-based entrepreneurship

1mo

✨✨💕

Anil Nair

In Silico Discovery, Designing drugs by leveraging SBDD, MD simulations and machine learning

1mo

Congrats Maximilien! 🎉

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics